Concepts (230)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Aging | 31 | 2023 | 352 | 5.040 |
Why?
|
| Brain | 23 | 2023 | 331 | 3.750 |
Why?
|
| Cognition | 23 | 2020 | 337 | 3.720 |
Why?
|
| Alzheimer Disease | 21 | 2023 | 409 | 3.120 |
Why?
|
| Cognitive Dysfunction | 14 | 2025 | 235 | 3.100 |
Why?
|
| Health Literacy | 5 | 2023 | 28 | 2.930 |
Why?
|
| Aged, 80 and over | 47 | 2025 | 1034 | 2.740 |
Why?
|
| Dementia | 10 | 2021 | 127 | 2.570 |
Why?
|
| Aged | 44 | 2025 | 1860 | 2.170 |
Why?
|
| Female | 51 | 2025 | 3346 | 2.140 |
Why?
|
| Longitudinal Studies | 25 | 2025 | 363 | 2.040 |
Why?
|
| Male | 48 | 2025 | 3399 | 1.990 |
Why?
|
| Humans | 60 | 2025 | 5837 | 1.950 |
Why?
|
| Neuropsychological Tests | 20 | 2020 | 309 | 1.640 |
Why?
|
| Cognition Disorders | 13 | 2018 | 237 | 1.580 |
Why?
|
| Decision Making | 5 | 2022 | 49 | 1.380 |
Why?
|
| DNA-Binding Proteins | 8 | 2019 | 94 | 1.250 |
Why?
|
| Neurodegenerative Diseases | 4 | 2018 | 39 | 1.230 |
Why?
|
| White Matter | 3 | 2018 | 24 | 1.140 |
Why?
|
| Disease Progression | 8 | 2019 | 157 | 0.950 |
Why?
|
| Lewy Bodies | 7 | 2019 | 56 | 0.840 |
Why?
|
| Magnetic Resonance Imaging | 6 | 2023 | 207 | 0.840 |
Why?
|
| Cohort Studies | 18 | 2019 | 406 | 0.810 |
Why?
|
| Independent Living | 5 | 2025 | 62 | 0.780 |
Why?
|
| TDP-43 Proteinopathies | 2 | 2020 | 20 | 0.760 |
Why?
|
| Crime Victims | 1 | 2022 | 9 | 0.740 |
Why?
|
| Blood Glucose | 1 | 2022 | 30 | 0.730 |
Why?
|
| Hypertension | 1 | 2022 | 35 | 0.720 |
Why?
|
| Memory, Episodic | 2 | 2019 | 26 | 0.710 |
Why?
|
| Perception | 2 | 2019 | 30 | 0.710 |
Why?
|
| Metacognition | 1 | 2021 | 3 | 0.700 |
Why?
|
| Hippocampus | 4 | 2019 | 61 | 0.670 |
Why?
|
| Limbic Encephalitis | 1 | 2020 | 4 | 0.650 |
Why?
|
| Neurofibrillary Tangles | 4 | 2017 | 33 | 0.650 |
Why?
|
| Brain Mapping | 2 | 2018 | 37 | 0.640 |
Why?
|
| Hospitalization | 2 | 2019 | 86 | 0.630 |
Why?
|
| Neurocognitive Disorders | 1 | 2019 | 9 | 0.610 |
Why?
|
| Memory, Short-Term | 1 | 2019 | 37 | 0.570 |
Why?
|
| Cerebral Amyloid Angiopathy | 2 | 2015 | 28 | 0.570 |
Why?
|
| Delay Discounting | 1 | 2018 | 4 | 0.560 |
Why?
|
| Delivery of Health Care | 1 | 2018 | 23 | 0.540 |
Why?
|
| Learning | 1 | 2018 | 23 | 0.540 |
Why?
|
| Cognitive Aging | 1 | 2018 | 27 | 0.540 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 24 | 0.530 |
Why?
|
| Literacy | 1 | 2017 | 9 | 0.520 |
Why?
|
| Ambulatory Care | 1 | 2017 | 16 | 0.520 |
Why?
|
| Chronic Disease | 1 | 2017 | 71 | 0.510 |
Why?
|
| Neuropathology | 1 | 2017 | 17 | 0.510 |
Why?
|
| Middle Aged | 12 | 2019 | 1775 | 0.490 |
Why?
|
| Agnosia | 1 | 2016 | 3 | 0.490 |
Why?
|
| Postmortem Changes | 1 | 2016 | 9 | 0.480 |
Why?
|
| Plaque, Amyloid | 2 | 2015 | 29 | 0.480 |
Why?
|
| Residence Characteristics | 3 | 2015 | 43 | 0.470 |
Why?
|
| Risk-Taking | 2 | 2011 | 16 | 0.430 |
Why?
|
| Apolipoprotein E4 | 4 | 2025 | 92 | 0.410 |
Why?
|
| Autopsy | 6 | 2019 | 67 | 0.400 |
Why?
|
| Geriatric Assessment | 2 | 2015 | 59 | 0.400 |
Why?
|
| Mortality | 2 | 2013 | 22 | 0.380 |
Why?
|
| Educational Status | 4 | 2017 | 60 | 0.380 |
Why?
|
| Depression | 5 | 2021 | 113 | 0.380 |
Why?
|
| Memory | 4 | 2018 | 61 | 0.360 |
Why?
|
| Motor Activity | 4 | 2015 | 83 | 0.360 |
Why?
|
| Polymorphism, Single Nucleotide | 4 | 2021 | 72 | 0.310 |
Why?
|
| Brain Infarction | 3 | 2018 | 23 | 0.300 |
Why?
|
| Sclerosis | 3 | 2019 | 26 | 0.300 |
Why?
|
| Prospective Studies | 6 | 2025 | 411 | 0.300 |
Why?
|
| Proportional Hazards Models | 4 | 2017 | 71 | 0.290 |
Why?
|
| Risk | 4 | 2018 | 60 | 0.290 |
Why?
|
| Genome-Wide Association Study | 3 | 2021 | 66 | 0.280 |
Why?
|
| Temporal Lobe | 2 | 2018 | 17 | 0.280 |
Why?
|
| Risk Factors | 5 | 2017 | 499 | 0.270 |
Why?
|
| Amyloid beta-Peptides | 2 | 2017 | 41 | 0.250 |
Why?
|
| Sex Characteristics | 3 | 2022 | 36 | 0.240 |
Why?
|
| Sex Factors | 4 | 2016 | 129 | 0.230 |
Why?
|
| Self Report | 2 | 2022 | 53 | 0.210 |
Why?
|
| Fraud | 1 | 2022 | 6 | 0.190 |
Why?
|
| Data Interpretation, Statistical | 1 | 2022 | 25 | 0.190 |
Why?
|
| Blood Pressure | 1 | 2022 | 48 | 0.180 |
Why?
|
| Age Factors | 4 | 2016 | 181 | 0.180 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 203 | 0.170 |
Why?
|
| Chicago | 2 | 2025 | 239 | 0.170 |
Why?
|
| Executive Function | 1 | 2021 | 31 | 0.170 |
Why?
|
| Linear Models | 2 | 2018 | 64 | 0.170 |
Why?
|
| Follow-Up Studies | 3 | 2017 | 333 | 0.170 |
Why?
|
| Disabled Persons | 2 | 2012 | 24 | 0.170 |
Why?
|
| Lewy Body Disease | 2 | 2018 | 29 | 0.160 |
Why?
|
| Comorbidity | 2 | 2018 | 98 | 0.150 |
Why?
|
| Awareness | 2 | 2016 | 13 | 0.150 |
Why?
|
| Income | 1 | 2019 | 3 | 0.150 |
Why?
|
| Muscle Strength | 2 | 2009 | 23 | 0.150 |
Why?
|
| Health Status | 1 | 2019 | 47 | 0.150 |
Why?
|
| Emergencies | 1 | 2019 | 18 | 0.140 |
Why?
|
| Frontal Lobe | 1 | 2018 | 17 | 0.140 |
Why?
|
| Demography | 1 | 2018 | 14 | 0.140 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2018 | 16 | 0.140 |
Why?
|
| Multifactorial Inheritance | 1 | 2018 | 2 | 0.140 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2018 | 7 | 0.140 |
Why?
|
| Cerebral Infarction | 2 | 2015 | 29 | 0.140 |
Why?
|
| Amyotrophic Lateral Sclerosis | 1 | 2018 | 8 | 0.140 |
Why?
|
| Frontotemporal Lobar Degeneration | 1 | 2018 | 7 | 0.140 |
Why?
|
| Surveys and Questionnaires | 2 | 2018 | 284 | 0.140 |
Why?
|
| Dementia, Vascular | 1 | 2018 | 7 | 0.140 |
Why?
|
| Mental Disorders | 1 | 2018 | 31 | 0.130 |
Why?
|
| Gene Expression | 1 | 2017 | 64 | 0.130 |
Why?
|
| RNA, Messenger | 1 | 2017 | 87 | 0.130 |
Why?
|
| Illinois | 1 | 2017 | 52 | 0.130 |
Why?
|
| DNA Methylation | 1 | 2017 | 72 | 0.130 |
Why?
|
| Memory Disorders | 2 | 2015 | 48 | 0.130 |
Why?
|
| Statistics as Topic | 1 | 2017 | 22 | 0.130 |
Why?
|
| Thyroid Neoplasms | 1 | 1996 | 7 | 0.120 |
Why?
|
| Prognosis | 1 | 2017 | 138 | 0.120 |
Why?
|
| Fetus | 1 | 2016 | 8 | 0.120 |
Why?
|
| Economics | 1 | 2016 | 3 | 0.120 |
Why?
|
| Comprehension | 1 | 2016 | 8 | 0.120 |
Why?
|
| Intelligence | 1 | 2016 | 8 | 0.120 |
Why?
|
| Brain Chemistry | 1 | 2016 | 11 | 0.120 |
Why?
|
| Anxiety Disorders | 1 | 2016 | 35 | 0.120 |
Why?
|
| Depressive Disorder, Major | 1 | 2016 | 28 | 0.120 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 66 | 0.120 |
Why?
|
| Mobility Limitation | 1 | 2015 | 16 | 0.110 |
Why?
|
| Organ Size | 1 | 2015 | 16 | 0.110 |
Why?
|
| Activities of Daily Living | 2 | 2012 | 75 | 0.110 |
Why?
|
| Personality | 1 | 2015 | 14 | 0.110 |
Why?
|
| Interpersonal Relations | 1 | 2014 | 26 | 0.110 |
Why?
|
| Clinical Trials as Topic | 1 | 2014 | 51 | 0.110 |
Why?
|
| Quality of Life | 1 | 2015 | 108 | 0.100 |
Why?
|
| Disability Evaluation | 2 | 2015 | 60 | 0.100 |
Why?
|
| Mesencephalon | 1 | 2013 | 11 | 0.100 |
Why?
|
| Neurons | 1 | 2013 | 90 | 0.100 |
Why?
|
| Motor Skills | 1 | 2012 | 8 | 0.090 |
Why?
|
| Neural Pathways | 1 | 2011 | 12 | 0.090 |
Why?
|
| Knowledge | 1 | 2010 | 6 | 0.080 |
Why?
|
| Nerve Degeneration | 1 | 2010 | 16 | 0.080 |
Why?
|
| Language | 1 | 2010 | 15 | 0.080 |
Why?
|
| Adult | 5 | 2018 | 1670 | 0.080 |
Why?
|
| Lung | 1 | 2009 | 31 | 0.080 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2009 | 12 | 0.080 |
Why?
|
| Kidney | 1 | 2009 | 35 | 0.070 |
Why?
|
| Severity of Illness Index | 3 | 2015 | 187 | 0.070 |
Why?
|
| Logistic Models | 3 | 2016 | 109 | 0.070 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2025 | 12 | 0.060 |
Why?
|
| Neurofilament Proteins | 1 | 2025 | 11 | 0.060 |
Why?
|
| tau Proteins | 1 | 2025 | 36 | 0.060 |
Why?
|
| Biomarkers | 1 | 2025 | 141 | 0.050 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2016 | 46 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2018 | 123 | 0.050 |
Why?
|
| Hair Dyes | 1 | 2002 | 1 | 0.050 |
Why?
|
| Alleles | 2 | 2015 | 89 | 0.050 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2021 | 4 | 0.040 |
Why?
|
| Breast Neoplasms | 1 | 2002 | 69 | 0.040 |
Why?
|
| Connecticut | 2 | 2002 | 3 | 0.040 |
Why?
|
| Mental Status and Dementia Tests | 1 | 2019 | 16 | 0.040 |
Why?
|
| Medicare | 1 | 2019 | 30 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 488 | 0.040 |
Why?
|
| Genetic Loci | 1 | 2018 | 16 | 0.030 |
Why?
|
| Reaction Time | 1 | 2018 | 39 | 0.030 |
Why?
|
| Protein-Arginine Deiminases | 1 | 2017 | 8 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2017 | 10 | 0.030 |
Why?
|
| alpha-Macroglobulins | 1 | 2017 | 11 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2017 | 13 | 0.030 |
Why?
|
| Child | 2 | 1996 | 339 | 0.030 |
Why?
|
| United States | 1 | 2019 | 502 | 0.030 |
Why?
|
| Arteriolosclerosis | 1 | 2016 | 14 | 0.030 |
Why?
|
| Young Adult | 1 | 2018 | 421 | 0.030 |
Why?
|
| Adenocarcinoma, Follicular | 1 | 1996 | 2 | 0.030 |
Why?
|
| Carcinoma, Papillary | 1 | 1996 | 5 | 0.030 |
Why?
|
| Radiotherapy | 1 | 1996 | 4 | 0.030 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 1996 | 3 | 0.030 |
Why?
|
| Time | 1 | 1996 | 4 | 0.030 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2016 | 64 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 3 | 0.030 |
Why?
|
| Computational Biology | 1 | 2016 | 7 | 0.030 |
Why?
|
| United Kingdom | 1 | 2016 | 11 | 0.030 |
Why?
|
| Neuroticism | 1 | 2016 | 6 | 0.030 |
Why?
|
| Gene-Environment Interaction | 1 | 2016 | 9 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2016 | 7 | 0.030 |
Why?
|
| Bipolar Disorder | 1 | 2016 | 16 | 0.030 |
Why?
|
| Schizophrenia | 1 | 2016 | 14 | 0.030 |
Why?
|
| Anisotropy | 1 | 2016 | 18 | 0.030 |
Why?
|
| Brain Stem | 1 | 2016 | 6 | 0.030 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2016 | 27 | 0.030 |
Why?
|
| Phenotype | 1 | 2016 | 96 | 0.030 |
Why?
|
| Incidence | 1 | 1996 | 165 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 2016 | 36 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 32 | 0.030 |
Why?
|
| Markov Chains | 1 | 2015 | 10 | 0.030 |
Why?
|
| Heterozygote | 1 | 2015 | 59 | 0.030 |
Why?
|
| Genotype | 1 | 2015 | 114 | 0.030 |
Why?
|
| Empathy | 1 | 2014 | 8 | 0.030 |
Why?
|
| Life Change Events | 1 | 2014 | 12 | 0.030 |
Why?
|
| Mental Recall | 1 | 2014 | 14 | 0.030 |
Why?
|
| Loneliness | 1 | 2014 | 22 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2015 | 112 | 0.030 |
Why?
|
| Psychometrics | 1 | 2014 | 52 | 0.030 |
Why?
|
| Animals | 1 | 1998 | 1349 | 0.030 |
Why?
|
| Stress, Psychological | 1 | 2014 | 58 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 163 | 0.030 |
Why?
|
| Time Factors | 1 | 2015 | 374 | 0.030 |
Why?
|
| Raphe Nuclei | 1 | 2013 | 5 | 0.030 |
Why?
|
| Locus Coeruleus | 1 | 2013 | 6 | 0.030 |
Why?
|
| Ventral Tegmental Area | 1 | 2013 | 6 | 0.030 |
Why?
|
| Cell Count | 1 | 2013 | 16 | 0.030 |
Why?
|
| Substantia Nigra | 1 | 2013 | 25 | 0.030 |
Why?
|
| Causality | 1 | 2012 | 7 | 0.020 |
Why?
|
| Sex Distribution | 1 | 2012 | 16 | 0.020 |
Why?
|
| Energy Metabolism | 1 | 2012 | 15 | 0.020 |
Why?
|
| Respiratory Tract Neoplasms | 1 | 1992 | 1 | 0.020 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1992 | 8 | 0.020 |
Why?
|
| Life Style | 1 | 2012 | 48 | 0.020 |
Why?
|
| Skin Neoplasms | 1 | 1992 | 19 | 0.020 |
Why?
|
| Games, Experimental | 1 | 2011 | 5 | 0.020 |
Why?
|
| Probability | 1 | 2011 | 22 | 0.020 |
Why?
|
| Nerve Net | 1 | 2011 | 18 | 0.020 |
Why?
|
| Oxygen | 1 | 2011 | 13 | 0.020 |
Why?
|
| Bone Neoplasms | 1 | 1992 | 30 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2012 | 111 | 0.020 |
Why?
|
| Exercise | 1 | 2012 | 96 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2009 | 8 | 0.020 |
Why?
|
| Microcirculation | 1 | 2009 | 13 | 0.020 |
Why?
|
| Atrophy | 1 | 2009 | 15 | 0.020 |
Why?
|
| Glomerular Filtration Rate | 1 | 2009 | 10 | 0.020 |
Why?
|
| Color | 1 | 2002 | 4 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2002 | 40 | 0.010 |
Why?
|
| Odds Ratio | 1 | 2002 | 60 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2002 | 136 | 0.010 |
Why?
|
| Pleural Neoplasms | 1 | 1992 | 2 | 0.010 |
Why?
|
| Europe | 1 | 1992 | 9 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1992 | 174 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 1992 | 153 | 0.010 |
Why?
|
| Infant | 1 | 1992 | 184 | 0.010 |
Why?
|